pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Cagrisema · news · pharmadog
← back to Cagrisema
News mentioning Cagrisema
12
stories
1d
Amylin design debate heats up as Lilly's crucial mid-stage weight loss data near
endpoints
2d
Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?
biospace
14d
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
fiercebiotech
15d
Lilly climbs, Novo falls as obesity drug battle intensifies
biopharma dive
15d
Novo CEO sees innovation as a matter of survival amid pipeline setbacks
biospace
16d
‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
fiercebiotech
16d
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
fiercebiotech
16d
Novo dips 6% on Wegovy pill stumble despite Q2 earnings beat
biospace
20d
Novo's IL-6 inhibitor fails in cardiovascular Phase 3, plunging shares more than 9%
biospace
22d
Novo ordered to face CagriSema fraud claims from shareholders: New Jersey court
biospace
22d
Novo Nordisk fails to dismiss lawsuit over CagriSema readout
fiercebiotech
May 6, 26
Novo hikes guidance on Wegovy pill’s fast sales start
biopharma dive
